{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:48:11Z","timestamp":1769280491387,"version":"3.49.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T00:00:00Z","timestamp":1384992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0079968","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T22:34:05Z","timestamp":1385073245000},"page":"e79968","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Rafael","family":"Sim\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleguer","family":"Plana-Ripoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Morros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Mundet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz M.","family":"Vilca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Procupet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M.","family":"Tabernero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Viol\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,11,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"E Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"SR Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00125-010-1933-3","article-title":"Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials","volume":"54","author":"JA Johnson","year":"2011","journal-title":"Diabetologia"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00125-009-1441-5","article-title":"Does diabetes therapy influence the risk of cancer?","volume":"52","author":"U Smith","year":"2009","journal-title":"Diabetologia"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13813450801954303","article-title":"Obesity and cancer: pathophysiological and biological mechanisms","volume":"114","author":"AG Renehan","year":"2008","journal-title":"Arch Physiol Biochem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"s867","DOI":"10.1093\/ajcn\/86.3.867S","article-title":"Metabolic syndrome, hyperinsulinemia, and cancer","volume":"86","author":"IR Hsu","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","article-title":"The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas","volume":"132","author":"E Giovannucci","year":"2007","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","article-title":"Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study","volume":"52","author":"LG Hemkens","year":"2009","journal-title":"Diabetologia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00125-009-1444-2","article-title":"Insulin glargine use and short-term incidence of malignancies\u2014a population-based follow-up study in Sweden","volume":"52","author":"JM Jonasson","year":"2009","journal-title":"Diabetologia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00125-009-1453-1","article-title":"Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group","volume":"52","author":"HM Colhoun","year":"2009","journal-title":"Diabetologia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e21368","DOI":"10.1371\/journal.pone.0021368","article-title":"Cancer risk associated with insulin glargine among adult type 2 diabetes patients- a nation-wide cohort study","volume":"6","author":"CH Chang","year":"2011","journal-title":"PLoS ONE"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1007\/s00125-011-2190-9","article-title":"Long-term effects of insulin glargine on the risk of breast cancer","volume":"54","author":"S Suissa","year":"2011","journal-title":"Diabetologia"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2337\/dc11-0699","article-title":"Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients","volume":"34","author":"NE Morden","year":"2011","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pcd.2011.10.004","article-title":"The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes","volume":"6","author":"M Lind","year":"2010","journal-title":"Prim Care Diabetes"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"SL Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/dmrr.736","article-title":"Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality","volume":"23","author":"M Monami","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-2007-992157","article-title":"Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients: a retrospective cohort study","volume":"116","author":"M Monami","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic and thyroid cancer with glucagon-like peptide-1\u2013based therapies","volume":"141","author":"M Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"JMM Evans","year":"2005","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"CJ Currie","year":"2009","journal-title":"Diabetologia"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"G Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and metaanalysis","volume":"3","author":"A Decensi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2337\/dc11-0512","article-title":"Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis","volume":"34","author":"ZJ Zhang","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"e33411","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis","volume":"7","author":"H Noto","year":"2012","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-012-2170-x","article-title":"Metformin and breast cancer risk: a meta-analysis and critical literature review","volume":"135","author":"NF Col","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1053\/j.gastro.2008.09.004","article-title":"Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus","volume":"135","author":"JD Lewis","year":"2008","journal-title":"Gastroeneterology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2006.07.2777","article-title":"Thiazolidinediones and risk of lung, prostate, and colon cancer in patients with diabetes","volume":"25","author":"R Govindarajan","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pds.1352","article-title":"Cancer risks in thiazolidinedione users compared to other anti-diabetic agents","volume":"16","author":"C Koro","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref29","first-page":"617","article-title":"Grupo SIDIAP: [SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research]","volume":"138","author":"B Bol\u00edbar","year":"2012","journal-title":"Med Clin (Barc)"},{"key":"ref30","first-page":"135","article-title":"Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP)","volume":"19","author":"MM Garc\u00eda-Gil","year":"2011","journal-title":"Inform Prim Care"},{"key":"ref31","first-page":"29","article-title":"Validity for use in research on vascular diseases of the SIDIAP (Information System for the Development of Research in Primary Care): the EMMA study","volume":"65","author":"R Ramos","year":"2012","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2337\/dc11-1679","article-title":"Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain)","volume":"35","author":"I Vinagre","year":"2012","journal-title":"Diabetes Care"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"251e","DOI":"10.1186\/1471-2458-13-251","article-title":"Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity","volume":"13","author":"C Viol\u00e1n","year":"2013","journal-title":"BMC Public Health"},{"key":"ref34","unstructured":"ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Version for 2007. World Health Organization. WHO international website. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/classifications\/apps\/icd\/icd10online\" xlink:type=\"simple\">http:\/\/www.who.int\/classifications\/apps\/icd\/icd10online<\/ext-link>. Accessed 2012 Sep 10."},{"key":"ref35","unstructured":"STROBE statement Website. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.strobstatement.org\/fileadmin\/Strobe\/uploads\/checklists\/STROBE_checklist_v4_case-control.pdf\" xlink:type=\"simple\">http:\/\/www.strobstatement.org\/fileadmin\/Strobe\/uploads\/checklists\/STROBE_checklist_v4_case-control. pdf<\/ext-link>. Accessed 2012 Sep 20."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5306\/wjco.v4.i2.43","article-title":"Statin a day keeps cancer at bay","volume":"4","author":"S Singh","year":"2013","journal-title":"World J Clin Oncol"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S (2000) Applied Logistic Regression. New York: John Wiley &amp; Sons, 2000.","DOI":"10.1002\/0471722146"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2337\/dc10-0476","article-title":"Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients","volume":"33","author":"E Mannucci","year":"2006","journal-title":"Diabetes Care"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00125-011-2312-4","article-title":"Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study","volume":"55","author":"R Ruiter","year":"2012","journal-title":"Diabetologia"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/dc11-0857","article-title":"Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study","volume":"35","author":"R Ruiter","year":"2012","journal-title":"Diabetes Care"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2337\/dc12-0506","article-title":"Does Insulin Glargine Increase the Risk of Cancer Compared With Other Basal Insulins?: A French nationwide cohort study based on national administrative databases","volume":"36","author":"JP Fagot","year":"2013","journal-title":"Diabetes Care"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"HC Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0030-1267203","article-title":"Review on the in vitro interaction of insulin glargine with the insulin\/insulin-like growth factor system: potential implications for metabolic and mitogenic activities","volume":"43","author":"TP Ciaraldi","year":"2011","journal-title":"Horm Metab Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e-41992","DOI":"10.1371\/journal.pone.0041992","article-title":"Effect of insulin analogues on insulin\/IGF1 hybrid receptors: increase activation by glargine but not by its metabolites M1 and M2","volume":"2102, 7","author":"C Pierre-Eugene","year":"2012","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1634\/theoncologist.2011-0462","article-title":"Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis","volume":"17","author":"D Soranna","year":"2012","journal-title":"Oncologist"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"928127","DOI":"10.1155\/2012\/928127","article-title":"Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis","volume":"2012","author":"R Rattan","year":"2012","journal-title":"J Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s00125-012-2653-7","article-title":"Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials","volume":"55","author":"RJ Stevens","year":"2012","journal-title":"Diabetologia"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/jnci\/djs328","article-title":"Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study","volume":"104","author":"R Mamtani","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00125-011-2390-3","article-title":"Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Reseach Database and secondary care data","volume":"55","author":"TP van Staa","year":"2012","journal-title":"Diabetologia"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ajg.2013.5","article-title":"Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"108","author":"S Singh","year":"2013","journal-title":"Am J Gastroenterol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0079968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T23:09:59Z","timestamp":1564873799000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0079968"}},"subtitle":[],"editor":[{"given":"Amar","family":"Abderrahmani","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,21]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0079968","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,21]]}}}